These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 29464943)

  • 1. Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device.
    Yin C; Wang Y; Ji J; Cai B; Chen H; Yang Z; Wang K; Luo C; Zhang W; Yuan C; Wang F
    Anal Chem; 2018 Mar; 90(6):3744-3751. PubMed ID: 29464943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
    Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
    Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
    Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
    BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system.
    Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y
    Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
    Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
    Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PLGA nanofiber microfluidic device for highly efficient isolation and release of different phenotypic circulating tumor cells based on dual aptamers.
    Wu Z; Pan Y; Wang Z; Ding P; Gao T; Li Q; Hu M; Zhu W; Pei R
    J Mater Chem B; 2021 Mar; 9(9):2212-2220. PubMed ID: 33616137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Isolation and Phenotypic Profiling of Circulating Hepatocellular Carcinoma Cells via a Combinatorial-Antibody-Functionalized Microfluidic Synergetic-Chip.
    Zhu L; Lin H; Wan S; Chen X; Wu L; Zhu Z; Song Y; Hu B; Yang C
    Anal Chem; 2020 Nov; 92(22):15229-15235. PubMed ID: 33124804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A micro-/nano-chip and quantum dots-based 3D cytosensor for quantitative analysis of circulating tumor cells.
    Wu X; Xiao T; Luo Z; He R; Cao Y; Guo Z; Zhang W; Chen Y
    J Nanobiotechnology; 2018 Sep; 16(1):65. PubMed ID: 30205821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.
    Sheng W; Ogunwobi OO; Chen T; Zhang J; George TJ; Liu C; Fan ZH
    Lab Chip; 2014 Jan; 14(1):89-98. PubMed ID: 24220648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analogous detection of circulating tumor cells using the AccuCyte
    van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
    Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.
    Theil G; Fischer K; Weber E; Medek R; Hoda R; Lücke K; Fornara P
    PLoS One; 2016; 11(8):e0158354. PubMed ID: 27479125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A microfluidic device for differential capture of heterogeneous rare tumor cells with epithelial and mesenchymal phenotypes.
    Wang X; Deng L; Gjertsen BT
    Anal Chim Acta; 2020 Sep; 1129():1-11. PubMed ID: 32891378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment and mutation detection of circulating tumor cells from blood samples.
    Kou R; Zhao J; Gogoi P; Carskadon S; Chow W; Hwang C; Palanisamy N; Leung C; Wang Y
    Oncol Rep; 2018 Jun; 39(6):2537-2544. PubMed ID: 29620284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic Profiling of Circulating Tumor Cells in Metastatic Prostate Cancer Patients Using Nanoparticle-Mediated Ranking.
    Green BJ; Nguyen V; Atenafu E; Weeber P; Duong BTV; Thiagalingam P; Labib M; Mohamadi RM; Hansen AR; Joshua AM; Kelley SO
    Anal Chem; 2019 Aug; 91(15):9348-9355. PubMed ID: 31264404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A platform for primary tumor origin identification of circulating tumor cells via antibody cocktail-based in vivo capture and specific aptamer-based multicolor fluorescence imaging strategy.
    Jia M; Mao Y; Wu C; Wang S; Zhang H
    Anal Chim Acta; 2019 Nov; 1082():136-145. PubMed ID: 31472702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D printed microfluidic devices for circulating tumor cells (CTCs) isolation.
    Chen J; Liu CY; Wang X; Sweet E; Liu N; Gong X; Lin L
    Biosens Bioelectron; 2020 Feb; 150():111900. PubMed ID: 31767348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating prostate cells during radical prostatectomy by standardized PSMA RT-PCR: association with positive lymph nodes and high malignant grade.
    Schmidt B; Anastasiadis AG; Seifert HH; Franke KH; Oya M; Ackermann R
    Anticancer Res; 2003; 23(5A):3991-9. PubMed ID: 14666708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.